Screener
Haemonetics HAE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | June 27, 2026 | March 28, 2026 |
|---|---|---|
| Accounts payable | 56,338 | 51,056 |
| Accrued payroll and related costs | 38,145 | 68,191 |
| Other current liabilities | 163,796 | 158,337 |
| Total current liabilities | 263,235 | 282,599 |
| Long-term debt | 1,169,202 | 1,219,565 |
| Deferred tax liability | 38,691 | 38,048 |
| Other long-term liabilities | 57,171 | 59,393 |
| Stockholders’ equity: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's total current liabilities?
- Haemonetics (HAE) reported total current liabilities of $263.24M in Q2 2026.
- How has Haemonetics's total current liabilities changed year-over-year?
- Haemonetics's total current liabilities decreased by 50.5% year-over-year, from $531.41M to $263.24M.
- What is the long-term trend for Haemonetics's total current liabilities?
- Over 5 years (2021 to 2026), Haemonetics's total current liabilities has grown at a 2.2% compound annual growth rate (CAGR), from $253.5M to $282.6M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Haemonetics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude